Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: TEVA PHARMACEUTICALS USA, INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-22 to 2023-02-28
Current total value of award: $610787.52
Description: 8509714861!ADENOVIRUS TYPE 4 A